Spin-off of the University of Verona and the University of Milan specialized in regenerative medicine for neurological diseases. After years of studies and research conducted by its founding scientists, Hemera is born to develop a revolutionary cellular therapy for the regeneration of damaged nerve tissues, which finds its first application in the treatment of acute spinal cord injuries.
| Website | https://hemerapharma.com/ |
| Employees | 12 (5 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Regenerative Medicine, Regenerative Therapies, Cell Therapy, Cell Based Therapies, Stem Cell Therapy, Drug Development, Advanced Therapies, Biotechnology, Pharmaceutical Research, Pharmaceutical, Clinical Trials, Fda Approval, Biologics, Healthcare, Life Sciences, Therapeutic Solutions, Biopharma, Medical Research, Neurology |
| Competitors | AbbVie, Amgen, Receptos, a wholly-owned subsidiary of Celgene, Gilead Sciences, Bristol Myers Squibb, Roche, Johnson & Johnson, Merck & Co., Inc., Novartis, Pfizer +48 more (view full list) |
Looking for a particular Hemera Pharma employee's phone or email?
Hemera Pharma Questions
Cristiana Vignoli is the CEO of Hemera Pharma.
5 people are employed at Hemera Pharma.
Top Hemera Pharma Employees
Related Companies
G2Crowd Trusted
300K+
Plugin Users
